High Point Bank & Trust’s Novartis NVS Stock Holding History

High Point Bank & Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$10K	Sell	154 -279	-64%	-$18.1K	﹤0.01%	346
2016 Q3	$31K	Hold	433	–	–	0.01%	267
2016 Q2	$32K	Hold	433	–	–	0.01%	252
2016 Q1	$28K	Hold	433	–	–	0.01%	263
2015 Q4	$34K	Hold	433	–	–	0.01%	260
2015 Q3	$36K	Hold	433	–	–	0.01%	267
2015 Q2	$39K	Sell	433 -218	-33%	-$20K	0.01%	259
2015 Q1	$58K	Hold	651	–	–	0.02%	229
2014 Q4	$54K	Hold	651	–	–	0.02%	240
2014 Q3	$55K	Hold	651	–	–	0.02%	231
2014 Q2	$53K	Hold	651	–	–	0.02%	236
2014 Q1	$50K	Sell	651 -558	-46%	-$40.7K	0.02%	241
2013 Q4	$87K	Hold	1,209	–	–	0.03%	200
2013 Q3	$83K	Buy	1,209 +37	+3%	+$2.45K	0.03%	206
2013 Q2	$74K	Buy	+1,172	New	+$76.3K	0.03%	210

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

High Point Bank & Trust's NVS Position: Q4 2016 in Review

High Point Bank & Trust reduced its Novartis (NVS) stake by 64% in Q4 2016, selling an estimated $18.1K and leaving 154 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #346.

High Point Bank & Trust first reported a position in NVS in Q2 2013 and has held it in 15 quarters since. The position peaked at $87K in Q4 2013. 904 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

High Point Bank & Trust held 154 shares of Novartis worth $10K as of Q4 2016.
High Point Bank & Trust sold 279 Novartis shares in Q4 2016, an estimated $18.1K.
Novartis made up ﹤0.01% of High Point Bank & Trust's portfolio in Q4 2016, its #346 holding.
High Point Bank & Trust first reported a position in Novartis in Q2 2013 and has held it in 15 quarters since.
High Point Bank & Trust's Novartis position peaked at $87K in Q4 2013.
904 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on High Point Bank & Trust's 13F filing for Q4 2016, filed 28 Feb 2017.